ACCELERATE DIAGNOSTICS INC (AXDX) Fundamental Analysis & Valuation

NASDAQ:AXDX • US00430H2013

Current stock price

0.034 USD
-0.05 (-61.36%)
At close:
0.052 USD
+0.02 (+52.94%)
After Hours:

This AXDX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AXDX Profitability Analysis

1.1 Basic Checks

  • In the past year AXDX has reported negative net income.
  • In the past year AXDX has reported a negative cash flow from operations.
  • In the past 5 years AXDX always reported negative net income.
  • In the past 5 years AXDX always reported negative operating cash flow.
AXDX Yearly Net Income VS EBIT VS OCF VS FCFAXDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -175.26%, AXDX is not doing good in the industry: 92.06% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -175.26%
ROE N/A
ROIC N/A
ROA(3y)-155.95%
ROA(5y)-129.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AXDX Yearly ROA, ROE, ROICAXDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

  • AXDX's Gross Margin of 23.12% is on the low side compared to the rest of the industry. AXDX is outperformed by 77.78% of its industry peers.
  • AXDX's Gross Margin has declined in the last couple of years.
  • AXDX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.89%
GM growth 5Y-13.35%
AXDX Yearly Profit, Operating, Gross MarginsAXDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. AXDX Health Analysis

2.1 Basic Checks

  • AXDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AXDX has more shares outstanding
  • The number of shares outstanding for AXDX has been increased compared to 5 years ago.
  • The debt/assets ratio for AXDX is higher compared to a year ago.
AXDX Yearly Shares OutstandingAXDX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
AXDX Yearly Total Debt VS Total AssetsAXDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -39.29, we must say that AXDX is in the distress zone and has some risk of bankruptcy.
  • AXDX has a worse Altman-Z score (-39.29) than 93.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -39.29
ROIC/WACCN/A
WACC0.32%
AXDX Yearly LT Debt VS Equity VS FCFAXDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • AXDX has a Current Ratio of 0.71. This is a bad value and indicates that AXDX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AXDX's Current ratio of 0.71 is on the low side compared to the rest of the industry. AXDX is outperformed by 92.59% of its industry peers.
  • A Quick Ratio of 0.62 indicates that AXDX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.62, AXDX is not doing good in the industry: 91.01% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.62
AXDX Yearly Current Assets VS Current LiabilitesAXDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. AXDX Growth Analysis

3.1 Past

  • AXDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.33%, which is quite impressive.
  • Looking at the last year, AXDX shows a decrease in Revenue. The Revenue has decreased by -2.97% in the last year.
  • The Revenue has been growing slightly by 4.69% on average over the past years.
EPS 1Y (TTM)35.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.09%
Revenue 1Y (TTM)-2.97%
Revenue growth 3Y-0.23%
Revenue growth 5Y4.69%
Sales Q2Q%-6.97%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y14.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.44%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AXDX Yearly Revenue VS EstimatesAXDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
AXDX Yearly EPS VS EstimatesAXDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. AXDX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AXDX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AXDX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXDX Price Earnings VS Forward Price EarningsAXDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXDX Per share dataAXDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXDX Dividend Analysis

5.1 Amount

  • AXDX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AXDX Fundamentals: All Metrics, Ratios and Statistics

ACCELERATE DIAGNOSTICS INC

NASDAQ:AXDX (5/14/2025, 8:20:36 PM)

After market: 0.052 +0.02 (+52.94%)

0.034

-0.05 (-61.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-22
Earnings (Next)08-06
Inst Owners18.91%
Inst Owner Change0%
Ins Owners4.32%
Ins Owner Change0%
Market Cap857.14K
Revenue(TTM)11.70M
Net Income(TTM)-50.05M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.21%
Min EPS beat(2)-23.07%
Max EPS beat(2)25.49%
EPS beat(4)2
Avg EPS beat(4)-2.97%
Min EPS beat(4)-23.07%
Max EPS beat(4)25.49%
EPS beat(8)4
Avg EPS beat(8)8.27%
EPS beat(12)8
Avg EPS beat(12)11.25%
EPS beat(16)9
Avg EPS beat(16)7.76%
Revenue beat(2)0
Avg Revenue beat(2)-5.99%
Min Revenue beat(2)-8.57%
Max Revenue beat(2)-3.41%
Revenue beat(4)0
Avg Revenue beat(4)-4.41%
Min Revenue beat(4)-8.57%
Max Revenue beat(4)-2.74%
Revenue beat(8)0
Avg Revenue beat(8)-9.77%
Revenue beat(12)2
Avg Revenue beat(12)-6.25%
Revenue beat(16)2
Avg Revenue beat(16)-9.26%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.67%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.38
EYN/A
EPS(NY)-2.04
Fwd EYN/A
FCF(TTM)-0.98
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS0.46
BVpS-2.22
TBVpS-2.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -175.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.12%
FCFM N/A
ROA(3y)-155.95%
ROA(5y)-129.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.89%
GM growth 5Y-13.35%
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.88%
Cap/Sales 4.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.62
Altman-Z -39.29
F-Score3
WACC0.32%
ROIC/WACCN/A
Cap/Depr(3y)21.67%
Cap/Depr(5y)26.83%
Cap/Sales(3y)5.75%
Cap/Sales(5y)6.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.09%
EPS Next Y14.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.97%
Revenue growth 3Y-0.23%
Revenue growth 5Y4.69%
Sales Q2Q%-6.97%
Revenue Next Year3.44%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.81%
OCF growth 3YN/A
OCF growth 5YN/A

ACCELERATE DIAGNOSTICS INC / AXDX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ACCELERATE DIAGNOSTICS INC?

ChartMill assigns a fundamental rating of 0 / 10 to AXDX.


Can you provide the valuation status for ACCELERATE DIAGNOSTICS INC?

ChartMill assigns a valuation rating of 0 / 10 to ACCELERATE DIAGNOSTICS INC (AXDX). This can be considered as Overvalued.


What is the profitability of AXDX stock?

ACCELERATE DIAGNOSTICS INC (AXDX) has a profitability rating of 0 / 10.


What is the financial health of ACCELERATE DIAGNOSTICS INC (AXDX) stock?

The financial health rating of ACCELERATE DIAGNOSTICS INC (AXDX) is 0 / 10.